Raphael Pharmaceutical Inc. (RAPH): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$210.0K

Year ended 2025-12-31

-$15.0K

Trailing 12 months to 2026-06-30

2020-12-31 Operating Cash Flow (USD) 2025-12-31

Period ended	Operating Cash Flow	Change YoY	Source filing
2025-12-31	-$210.0K	n/m	2026-03-31, From 2025-01-01
2024-12-31	-$532.0K	n/m	2026-03-31, From 2024-01-01
2023-12-31	-$1.20M	n/m	2025-03-31, From 2023-01-01
2022-12-31	-$759.0K	n/m	2024-03-28, From 2022-01-01
2021-12-31	-$1.42M	n/m	2023-05-25, From 2021-01-01
2020-12-31	-$779.0K	n/a	2022-03-30, From 2020-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Operating Cash Flow	Change YoY
Raphael Pharmaceutical Inc. (RAPH)	2025-12-31	-$210.0K	n/m
China Foods Holdings Ltd. (CFOO)	2025-12-31	-$389.3K	n/m
Nutra Pharma Corp (NPHC)	2025-12-31	-$1.16M	n/m
Adia Nutrition, Inc. (ADIA)	2025-12-31	-$179.2K	n/m
Aibotics, Inc. (AIBT)	2025-12-31	-$458.2K	n/m
TFA Therapeutics, Inc. (RAJAF)	2025-12-31	-$35.8K	n/m
Regencell Bioscience Holdings Ltd (RGC)	2025-06-30	-$3.11M	n/m
Target Group Inc. (CBDY)	2025-12-31	-$842.4K	n/m
Functional Brands Inc. (MEHA)	2025-12-31	-$1.27M	n/m

Compare RAPH, CFOO, NPHC, ADIA side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗